IDI Pharma

IDI Pharma (IDI Integratori Dietetici Italiani S.r.l.) is an Italian pharmaceutical company specializing in the research, development, and commercialization of innovative nutraceuticals, medical devices, and dermocosmetics. Founded in 1997, the company focuses on specialized therapeutic areas including urology, gynecology, sexuality, and couples' fertility. IDI Pharma's product portfolio features patented formulations and unique dosage technologies designed to address oxidative stress, hormonal imbalances, and chronic inflammatory conditions. Key commercial products include Deprox for prostatitis, Spergin for male fertility, and FT500 Plus for female reproductive health. The company operates from its headquarters in Sicily and is actively expanding its international distribution network.